challenges and opportunities of digital therapeutics in the EU

Digital therapeutics, in the form of software designed to treat disorders and diseases, are spreading at varying rates across countries ...

improving access to digital therapeutics in europe | efpia

28 Specifically, there are four major challenges impeding access to digital therapeutics: ... How digital therapy benefits patients ...

POSB295 Challenges and Opportunities for Digital Therapeutics

Despite significant technological advances, frameworks for the assessment and reimbursement for DTx are still evolving across the EU, UK, and US. This research.

Digital Therapeutics: Challenges and Opportunities

Some healthcare providers might refuse to adopt software development of digital therapeutics and insist on using a traditional pharmaceutical ...

Challenges and opportunities for digital therapeutics

... therapeutics: key requirements to demonstrate value across the EU, England and the US. Nasos Kipentzoglou presents new research at ISPOR Europe ...

Navigating the Digital Therapeutic Landscape: Challenges and ...

Compliance with these regulations is critical to ensure the safety and efficacy of DTx products. However, obtaining regulatory approval can be a ...

Digital Therapeutics Market Size Growth in Europe and The US

The research suggests that the market will increase at a CAGR of 23.4% and reach 10,639.36 million digital therapeutics revenue by 2028. DTx EU ...

key requirements to demonstrate value across the EU, England and ...

Challenges and opportunities for digital therapeutics: key requirements to demonstrate value across the. EU, England and the US. Kipentzoglou N1, Zegaoui Y1 ...

Digital therapeutics in Europe: what is the state of play?

... therapeutic benefits. This is an important potentiality, whose ... The challenge is to guarantee that the physician does not incur ...

DTx: where do EU regulations stand in this emerging, rapidly ...

Digital Therapeutics (DTx), which first appeared around 16 years ago, are a type of medical device (some even say a new kind of medicine),[1] ...

Market Access 2023 | How to solve a problem like DTx in Europe?

Digital Therapeutics have been praised for their potential in healthcare, yet the path to market remains fragmented. Healthware's Alberta Spreafico ...

POSB295 Challenges and Opportunities for Digital Therapeutics

POSB295 Challenges and Opportunities for Digital Therapeutics: Key Requirements to Demonstrate Value Across the EU, UK, and US.

Digital Therapeutics (DTx) - European Data Protection Supervisor

For example, Digital Therapeutics can support patients in self-managing symptoms and thereby improve their quality of life and other clinical endpoints. DTx ...

Digital Therapeutics in Perspective: From Regulatory Challenges to ...

One of the main issues related to DTx is the general lack of education of healthcare professionals in this sector that leads to a knowledge gap between data ...

Success Factors for Scaling Up the Adoption of Digital Therapeutics ...

We investigated how the approval and adoption of DTx within health systems have been approached in five selected European countries and regions, with a view to ...

EFPIA recommendations for access to digital therapies in the EU

The use of digital therapies in the EU is still limited, despite the fact that the Covid-19 pandemic boosted the development and implementation ...

Review Therapeutic innovation and digital therapies in the world ...

This lack would risk incorrectly classifying real therapies, subjected to clinical trials, often very different from each other and with a real impact on ...

Towards harmonizing assessment and reimbursement of digital ...

Digital medical devices (DMDs) present unique opportunities in their regulation and reimbursement. A dynamic landscape of DMD assessment ...

Key Requirements to Demonstrate Value Across the EU, UK, and US

POSB295 Challenges and Opportunities for Digital Therapeutics: Key Requirements to Demonstrate Value Across the EU, UK, and US · Objectives · Methods · Results.

IP for Digital Therapeutics: Opportunities and Challenges | 4.12.23

In this space, a significant part of a company's value typically lies in its intellectual property (IP). However, in the European patent system, digital ...